Staphylococcus aureus with heterogeneous resistance to vancomycin: epidemiology, clinical significance, and critical assessment of diagnostic methods.
about
Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemicVancomycin heteroresistance in bloodstream isolates of Staphylococcus capitisReduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implicationsInvestigation of Staphylococcus strains with heterogeneous resistance to glycopeptides in a Turkish university hospitalCatheter-related bloodstream infection in end-stage kidney disease: a Canadian narrative reviewSystematic Review and Meta-Analysis of the Epidemiology of Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Staphylococcus aureus IsolatesMechanisms of vancomycin resistance in Staphylococcus aureusTreatment of Gram-positive infections in critically ill patientsMethicillin-resistant Staphylococcus aureus: an evolutionary, epidemiologic, and therapeutic odysseyNational surveillance of methicillin-resistant Staphylococcus aureus in Belgian hospitals indicates rapid diversification of epidemic clones.Evaluation of high-dose daptomycin for therapy of experimental Staphylococcus aureus foreign body infection.Detection and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates in Canada: results from the Canadian Nosocomial Infection Surveillance Program, 1995-2006.Real-time PCR testing for mecA reduces vancomycin usage and length of hospitalization for patients infected with methicillin-sensitive staphylococci.Ceftaroline-heteroresistant Staphylococcus aureus.Antimicrobial susceptibilities of health care-associated and community-associated strains of methicillin-resistant Staphylococcus aureus from hospitalized patients in Canada, 1995 to 2008Intensive therapy with ceftobiprole medocaril of experimental foreign-body infection by methicillin-resistant Staphylococcus aureusExposure of Staphylococcus aureus to subinhibitory concentrations of β-lactam antibiotics induces heterogeneous vancomycin-intermediate Staphylococcus aureusCharacterization of heterogeneous vancomycin-intermediate resistance, MIC and accessory gene regulator (agr) dysfunction among clinical bloodstream isolates of staphyloccocus aureusUnderestimation of vancomycin and teicoplanin MICs by broth microdilution leads to underdetection of glycopeptide-intermediate isolates of Staphylococcus aureus.tcaA inactivation increases glycopeptide resistance in Staphylococcus aureus.Methicillin and Vancomycin Resistant S. aureus in Hospitalized Patients.Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children.In vitro activity of linezolid against key gram-positive organisms isolated in the united states: results of the LEADER 2004 surveillance program.Comparative efficacies of human simulated exposures of telavancin and vancomycin against methicillin-resistant Staphylococcus aureus with a range of vancomycin MICs in a murine pneumonia model.Vancomycin pharmacokinetics and pharmacodynamics during short daily hemodialysisA small RNA controls a protein regulator involved in antibiotic resistance in Staphylococcus aureusMechanisms of antibiotic resistance in Staphylococcus aureus.Site-specific mutation of Staphylococcus aureus VraS reveals a crucial role for the VraR-VraS sensor in the emergence of glycopeptide resistance.Reduced vancomycin susceptibility found in methicillin-resistant and methicillin-sensitive Staphylococcus aureus clinical isolates in Northeast China.Transcriptomic and functional analysis of an autolysis-deficient, teicoplanin-resistant derivative of methicillin-resistant Staphylococcus aureus.Isolates with low-level vancomycin resistance associated with persistent methicillin-resistant Staphylococcus aureus bacteremia.Clinical and laboratory characteristics of invasive infections due to methicillin-resistant Staphylococcus aureus isolates demonstrating a vancomycin MIC of 2 micrograms per milliliter: lack of effect of heteroresistant vancomycin-intermediate S. auRapid induction of high-level carbapenem resistance in heteroresistant KPC-producing Klebsiella pneumoniae.Quality control guidelines for BAL9141 (Ro 63-9141), an investigational cephalosporin, when reference MIC and standardized disk diffusion susceptibility test methods are used.Confronting bacterial resistance in healthcare settings: a crucial role for microbiologists.Prevalence and characteristics of heteroresistant vancomycin-intermediate Staphylococcus aureus bacteremia in a tertiary care centerHigh prevalence of isolates with reduced glycopeptide susceptibility in persistent or recurrent bloodstream infections due to methicillin-resistant Staphylococcus aureus.Synergistic activity of ceftobiprole and vancomycin in a rat model of infective endocarditis caused by methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus.Clinical outcomes and molecular typing of heterogenous vancomycin-intermediate Staphylococcus aureus bacteremia in patients in intensive care unitsInvestigation of reduced susceptibility to glycopeptides among methicillin-resistant Staphylococcus aureus isolates from patients in Ireland and evaluation of agar screening methods for detection of heterogeneously glycopeptide-intermediate S. aureu
P2860
Q24614464-18133BFB-B7B3-4FF8-A351-44DCDD2DA5FAQ24646621-AE0D9CD8-5E08-47F8-9487-634D759522B4Q24646677-73463D99-51C1-4E6E-99CA-18BAE97A28ADQ24810927-1E3C1D47-B890-49DD-A05E-3B5492E85298Q26751691-ACFF95B2-5C26-4048-B9C1-9BE4A5D8F0C9Q26796560-6DF77AEB-E396-41C7-B02D-A68347A6745BQ26829312-F1D0A376-6ACF-4DF2-B84C-50AC454B6220Q27015976-AC982C94-9D96-41BC-B053-98610C09235FQ28235095-E00307C2-36EC-44D0-81B5-4D12EB8268BEQ30342769-09F9EE44-967C-42E9-9077-B48607597CA3Q33239640-7918A086-D595-48A7-BC6B-19BD3571FD3BQ33613735-7F415DE2-CEA9-4AE2-9538-1B37412B672CQ33704733-E04E865D-09A0-4545-B014-613E2D63EFEDQ33798069-8694F766-FA04-4B69-82A6-F22137FFECA9Q33826253-4B2D852D-565F-4B54-B0BE-597653C2F1CEQ33935282-E1BFBA80-966E-4213-A2C6-D1BE6B772532Q34057324-2AA966F3-92A6-45C5-ABC2-CA37113E044FQ34057548-0C2C6B80-3A62-47CA-BFED-5BE920F3C304Q34108614-981A799D-CDF5-469B-BAF5-DED456D690C6Q34141289-08346B1C-3B99-467A-9C52-D9E5A3B32303Q34142160-E45547B6-297E-44F1-8C9A-6588A106B92CQ34157657-29D81106-7031-4DDF-83B5-D7A27ACFBCDEQ34228269-1F7EC535-34F3-45FF-93F5-51F0C80ECA7CQ34309620-7C4BB76D-E58B-4211-8ED8-7E0DFDA9662FQ34405301-7680076B-0528-40D3-B3A5-12D73C3D4611Q34405826-E242DE97-1196-4E61-AC87-9CAAD5C140B5Q34657311-D752D390-370D-40DB-90CB-270A72314111Q34737155-F37F4CAA-A34C-4453-8CB7-39BBFE6425C9Q34998629-B6F3CAAA-F05C-411C-8B53-32E1301828BBQ35023285-10AA1320-C3C7-43EF-B4C0-3CBADD00D794Q35023343-D7D6A87B-562E-44BE-85AC-374C931934C6Q35066896-5DBF309C-C905-4FE8-813F-E2511B082D4DQ35607909-F19D062F-B8B0-4896-B87D-6BB320E926B1Q35715050-D2CA89ED-A181-419D-A95D-8C2E6B9E0EF2Q35745242-8EA40845-0BB6-48A8-B0A7-564B3CBF510FQ35784453-400813A3-F6DE-46A2-BDDD-8E3A42977B28Q35806306-A6BB3F4B-C62A-41F0-AAB9-BD91201F3915Q35806369-649AED19-E2D1-45FC-B6A9-0C3EF8E2CD4DQ35819831-1D429EA1-E827-4377-8704-EA0DBD4E3A50Q36098762-5A477613-4A72-4369-AD7B-798B4144CBFC
P2860
Staphylococcus aureus with heterogeneous resistance to vancomycin: epidemiology, clinical significance, and critical assessment of diagnostic methods.
description
2003 nî lūn-bûn
@nan
2003 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Staphylococcus aureus with het ...... essment of diagnostic methods.
@ast
Staphylococcus aureus with het ...... essment of diagnostic methods.
@en
type
label
Staphylococcus aureus with het ...... essment of diagnostic methods.
@ast
Staphylococcus aureus with het ...... essment of diagnostic methods.
@en
prefLabel
Staphylococcus aureus with het ...... essment of diagnostic methods.
@ast
Staphylococcus aureus with het ...... essment of diagnostic methods.
@en
P2860
P1476
Staphylococcus aureus with het ...... essment of diagnostic methods.
@en
P2093
Catherine Liu
Henry F Chambers
P2860
P304
P356
10.1128/AAC.47.10.3040-3045.2003
P407
P577
2003-10-01T00:00:00Z